Chimerix, Inc.
CMRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $34 | $2 |
| % Growth | -34.6% | -99% | 1,609.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $33 | $2 |
| % Margin | 100% | 100% | 98.7% | 76.4% |
| R&D Expenses | $75 | $69 | $72 | $74 |
| G&A Expenses | $22 | $25 | $22 | $19 |
| SG&A Expenses | $22 | $25 | $22 | $19 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $97 | $93 | $94 | $92 |
| Operating Income | -$97 | -$93 | -$60 | -$173 |
| % Margin | -45,550.5% | -28,723.8% | -178.5% | -8,762% |
| Other Income/Exp. Net | $8 | $11 | $233 | $0 |
| Pre-Tax Income | -$88 | -$82 | $172 | -$173 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$88 | -$82 | $172 | -$256 |
| % Margin | -41,692% | -25,338% | 509% | -12,925.5% |
| EPS | -0.99 | -0.93 | 1.97 | -3.01 |
| % Growth | -6.5% | -147.2% | 165.4% | – |
| EPS Diluted | -0.99 | -0.93 | 1.94 | -3.01 |
| Weighted Avg Shares Out | 90 | 89 | 88 | 85 |
| Weighted Avg Shares Out Dil | 90 | 89 | 89 | 85 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $11 | $3 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$96 | -$93 | -$60 | -$90 |
| % Margin | -45,506.1% | -28,695.7% | -178.2% | -4,565.1% |